PineBridge Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Sell
4,949
-863
-15% -$442K 0.02% 293
2025
Q4
$3.26M Buy
5,812
+3,046
+110% +$1.73M 0.02% 294
2025
Q3
$1.42M Sell
2,766
-18,663
-87% -$8.15M 0.01% 392
2025
Q2
$6.73M Sell
21,429
-1,041
-5% -$313K 0.05% 264
2025
Q1
$6.85M Buy
22,470
+9,829
+78% +$3.31M 0.05% 271
2024
Q4
$4.2M Sell
12,641
-13,309
-51% -$4.51M 0.03% 343
2024
Q3
$8.66M Buy
25,950
+2,350
+10% +$893K 0.07% 238
2024
Q2
$9.72M Buy
23,600
+2,268
+11% +$898K 0.08% 226
2024
Q1
$8.62M Sell
21,332
-5,755
-21% -$2.02M 0.07% 266
2023
Q4
$8.3M Buy
27,087
+20,852
+334% +$5.63M 0.08% 236
2023
Q3
$1.51M Buy
6,235
+6,088
+4,141% +$1.56M 0.02% 398
2023
Q2
$35.3K Buy
+147
New +$30.5K ﹤0.01% 719
2020
Q1
Sell
-13,400
Closed -$1.13M 922
2019
Q4
$1.13M Sell
13,400
-7,781
-37% -$602K 0.02% 538
2019
Q3
$1.78M Sell
21,181
-1,162
-5% -$87.8K 0.03% 458
2019
Q2
$1.46M Buy
22,343
+16,098
+258% +$928K 0.02% 476
2019
Q1
$369K Buy
+6,245
New +$373K 0.01% 758

Other funds holding MEDP

PineBridge Investments's MEDP Position: Q1 2026 in Review

PineBridge Investments reduced its Medpace (MEDP) stake by 15% in Q1 2026, selling an estimated $442K and leaving 4,949 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #293.

PineBridge Investments first reported a position in MEDP in Q1 2019 and has held it in 16 quarters since. The position peaked at $9.72M in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • PineBridge Investments held 4,949 shares of Medpace worth $2.38M as of Q1 2026.
  • PineBridge Investments sold 863 Medpace shares in Q1 2026, an estimated $442K.
  • Medpace made up 0.02% of PineBridge Investments's portfolio in Q1 2026, its #293 holding.
  • PineBridge Investments first reported a position in Medpace in Q1 2019 and has held it in 16 quarters since.
  • PineBridge Investments's Medpace position peaked at $9.72M in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.